Epileptic patients and especially parents of children with the condition believe that the cannabidiol component of marijuana was effective, but there remains little solid evidence that it was not just a placebo effect, researchers said here.

Two surveys of parents of children with severe seizure disorders, presented at the American Epilepsy Society annual meeting, found high rates of perceived efficacy, particularly for Lennox-Gastaut syndrome and infantile spasms.

But the authors of those studies said the results were, in the words of one, “too good to be true” and in direct conflict with their own experiences in seeing patients taking cannabidiol-based products.

READ FULL ARTICLE Curated publisher From Medical Page Today